|
Volumn 22, Issue 2, 2002, Pages 102-112
|
Immunohistochemistry and genotype analysis of tumors. First part: Which future for the immunochemical diagnosis of cancer?;Confrontation immunohistochimique et analyse génotypique des tumeurs. Premiè partie: Quel futur pour le diagnostic immunohistochimique des cancers?
a a |
Author keywords
Fusion proteins; hMLH1; hMSH2; Immunohistochemistry; Oncogenes; p53
|
Indexed keywords
CELL PROTEIN;
CHIMERIC PROTEIN;
DNA;
GENE PRODUCT;
HYBRID PROTEIN;
PROTEIN BAX;
PROTEIN BCL 2;
PROTEIN MLH1;
PROTEIN MSH2;
PROTEIN P53;
STEM CELL FACTOR RECEPTOR;
ARTICLE;
BREAST CARCINOMA;
CANCER;
CANCER DIAGNOSIS;
CANCER THERAPY;
CARCINOGENESIS;
COLORECTAL CANCER;
DIGESTIVE SYSTEM CANCER;
DNA REPAIR;
EWING SARCOMA;
FAMILIAL CANCER;
GENE ACTIVATION;
GENE MUTATION;
GENE OVEREXPRESSION;
GENOTYPE;
HUMAN;
HUMAN TISSUE;
IMMUNOHISTOCHEMISTRY;
LARGE CELL LYMPHOMA;
ONCOGENE;
ONCOGENE C KIT;
ONCOGENE NEU;
PROGNOSIS;
PROTO ONCOGENE;
SMALL CELL SARCOMA;
TUMOR SUPPRESSOR GENE;
GENETIC TECHNIQUES;
GENOTYPE;
HUMANS;
IMMUNOHISTOCHEMISTRY;
NEOPLASM PROTEINS;
NEOPLASMS;
RECOMBINANT FUSION PROTEINS;
|
EID: 0036234225
PISSN: 02426498
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (6)
|
References (71)
|